Angstrom Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 3

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $3M

  • Investors
  • 1

Angstrom General Information

Description

Developer of diagnostics technology designed for accuracy and frequency of COVID-19 and respiratory pathogen testing. The company's technology is nanopore sequencing and a machine learning-powered platform that counts individual deoxyribonucleic acid molecules that pass through each of hundreds of nano-scale pores in a specially-designed membrane, seeking to minimize patient discomfort and organizational disruption, enabling testing laboratories to have access to repeated, high-quality testing.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1108 Lavaca Street
  • Suite 110-329
  • Austin, TX 78701
  • United States
+1 (314)
Primary Industry
Decision/Risk Analysis
Corporate Office
  • 1108 Lavaca Street
  • Suite 110-329
  • Austin, TX 78701
  • United States
+1 (314)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Angstrom Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC (Series A) 04-Jun-2021 $3M Completed Generating Revenue
To view Angstrom’s complete valuation and funding history, request access »

Angstrom Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
To view Angstrom’s complete cap table history, request access »

Angstrom Patents

Angstrom Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3173190-A1 Assays for detecting pathogens Pending 24-Mar-2020
EP-4127233-A1 Assays for detecting pathogens Inactive 24-Mar-2020
EP-4127233-A4 Assays for detecting pathogens Inactive 24-Mar-2020
US-20240240267-A1 Assays for detecting pathogens Inactive 24-Mar-2020
WO-2021191829-A1 Assays for detecting pathogens Inactive 24-Mar-2020 C12Q1/701
To view Angstrom’s complete patent history, request access »

Angstrom Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Angstrom Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
GreyBird Ventures Venture Capital Minority
To view Angstrom’s complete investors history, request access »

Angstrom FAQs

  • When was Angstrom founded?

    Angstrom was founded in 2019.

  • Where is Angstrom headquartered?

    Angstrom is headquartered in Austin, TX.

  • What is the size of Angstrom?

    Angstrom has 3 total employees.

  • What industry is Angstrom in?

    Angstrom’s primary industry is Decision/Risk Analysis.

  • Is Angstrom a private or public company?

    Angstrom is a Private company.

  • What is the current valuation of Angstrom?

    The current valuation of Angstrom is .

  • What is Angstrom’s current revenue?

    The current revenue for Angstrom is .

  • How much funding has Angstrom raised over time?

    Angstrom has raised $3M.

  • Who are Angstrom’s investors?

    GreyBird Ventures has invested in Angstrom.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process